Overview Evaluation of Reader Training Processes Status: Completed Trial end date: 2014-08-01 Target enrollment: Participant gender: Summary This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers. Phase: Phase 4 Details Lead Sponsor: Avid Radiopharmaceuticals